<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Approach to flushing in adults
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Approach to flushing in adults
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Approach to flushing in adults
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Sara B Fazio, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Mark D Aronson, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Karen Law, MD, FACP
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Apr 19, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Flushing, a common problem encountered in the practice of medicine, has a broad differential diagnosis. A detailed history including associated symptoms, duration, tempo, and environmental exposure is important to determine the underlying etiology and to formulate a management plan.
        </p>
        <p>
         This topic reviews the pathogenesis, differential diagnosis, evaluation, and treatment of flushing. The management of benign excessive sweating as well as the approach to the patient with night sweats are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5567.html" rel="external">
          "Primary focal hyperhidrosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2768.html" rel="external">
          "Evaluation of the patient with night sweats or generalized hyperhidrosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          DEFINITION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Flushing is a sensation of warmth accompanied by transient erythema that most commonly occurs on the face but may also involve the neck, ears, chest, epigastrium, and arms or other areas [
         <a href="#rid1">
          1
         </a>
         ]. The predilection for specific anatomical areas is likely to relate to the volume of visible superficial vessels and differences in the relative amount of cutaneous blood flow compared with other body areas [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
         It is important to differentiate "true flushing" from other disorders that lead to facial erythema, such as the butterfly rash associated with systemic lupus erythematosus or photosensitivity reactions [
         <a href="#rid3">
          3
         </a>
         ]. It is also important to distinguish flushing from excess sweating alone.
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          PATHOGENESIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Flushing is a consequence of increased cutaneous blood flow secondary to vasodilation and represents part of a synchronized physiologic response of cutaneous vascular smooth muscle to a variety of autonomic or vasodilator stimuli. Flushing may be episodic, transient, or constant, depending on the etiology.
        </p>
        <p>
         The appearance of a patient with flushing varies depending on the skin color, temperature, visibility of blood vessels beneath the skin, and capacitance of those vessels for erythrocytes [
         <a href="#rid1">
          1
         </a>
         ]. A fixed degree of facial erythema and telangiectasias may be seen in patients who have experienced flushing over many years [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p>
         Vascular smooth muscle responds to both autonomic innervation and circulating vasoactive agents; changes in either of these factors can lead to a flushing response. Autonomic nerves also innervate eccrine sweat glands. Thus, disorders of the autonomic nervous system tend to cause vasodilation accompanied by sweating, whereas vasoactive substances, either endogenous or exogenous, tend to cause flushing reactions alone. Autonomic-mediated flushing is often referred to as a "wet" flush, whereas vasoactive-mediated flushing is referred to as a "dry" flush [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
         Vasomotor innervation of specific cutaneous vessels involves either vasoconstrictor or vasodilator fibers; in most areas of the body, one will predominate over the other. Cutaneous vessels in the face are primarily innervated by vasodilator fibers that originate in the brainstem and exit with the trigeminal nerve [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h1">
          ETIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         The differential diagnosis of flushing is broad (
         <a class="graphic graphic_table graphicRef53013" href="/z/d/graphic/53013.html" rel="external">
          table 1
         </a>
         ). Neural (autonomic) mediated flushing syndromes can be classified as thermoregulatory flushing, emotional flushing, and flushing related to a disorder of the central nervous system. Direct vasodilator-mediated flushing syndromes result from exposure to a variety of exogenous substances that have a direct effect on the vascular smooth muscle or a number of systemic disorders associated with overproduction of vasoactive agents.
        </p>
        <p>
         An approach to the evaluation of patients with flushing is shown in an algorithm (
         <a class="graphic graphic_algorithm graphicRef68454" href="/z/d/graphic/68454.html" rel="external">
          algorithm 1
         </a>
         ) and discussed below. (See
         <a class="local">
          'Evaluation'
         </a>
         below.)
        </p>
        <p>
         The most common etiologies of flushing are [
         <a href="#rid2">
          2
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Fever
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hyperthermia
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Menopause
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Emotional blushing
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Rosacea
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          Autonomic mediated flushing
         </span>
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h3">
          Thermoregulatory flushing
         </span>
         <span class="headingEndMark">
          —
         </span>
         All forms of thermoregulatory flushing are associated with diaphoresis, which is the body's attempt to bring the core body temperature back to baseline. Thermoregulatory flushing can be caused by:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Fever
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Exercise
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Heat exposure: ambient or ingested hot beverage
        </p>
        <p>
        </p>
        <p>
         Fever is readily diagnosed by an elevated temperature and may be caused by a variety of infectious and noninfectious etiologies. An increase in body temperature, either by exposure (ie, a very hot day) or exercise will induce a similar response.
        </p>
        <p>
         The ingestion of a hot beverage appears to induce flushing by a countercurrent heat exchange between the internal jugular vein and the carotid artery [
         <a href="#rid6">
          6
         </a>
         ]. Transmission of heat via the carotid to the anterior hypothalamus, which is exquisitely sensitive to temperature, causes a rapid flushing and sweating response. Thermoregulatory flushing can typically be avoided by allowing a hot drink to cool slightly prior to ingestion and mitigated by consuming a cold beverage or ice.
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h3">
          Menopause
         </span>
         <span class="headingEndMark">
          —
         </span>
         A particularly common and uncomfortable form of thermoregulatory flushing is seen around the time of menopause and is secondary to decreasing levels of circulating estrogen. The flushing reaction is best known as a "hot flash." (See
         <a class="medical medical_review" href="/z/d/html/7390.html" rel="external">
          "Menopausal hot flashes"
         </a>
         .)
        </p>
        <p>
         Symptoms related to hot flashes characteristically consist of episodic sensations of heat, intense sweating, and flushing [
         <a href="#rid7">
          7
         </a>
         ]. An estimated 50 to 80 percent of women over the age of 45 suffer from these symptoms. Surgically induced menopause tends to cause more severe symptoms, particularly in the first year [
         <a href="#rid8">
          8
         </a>
         ]. Typical episodes last from three to five minutes and may occur up to 20 times per day [
         <a href="#rid9">
          9
         </a>
         ]. They are often very uncomfortable and anxiety-provoking, and they can interfere with sleep as well as normal daily functioning.
        </p>
        <p>
         The decrease in circulating estrogen appears to stimulate a sudden downward resetting of the body's thermostat in the hypothalamus that precedes the hot flash via unclear mechanisms. The alternation in set point causes a sensation of extreme heat and concomitant activation of both physiologic and behavioral heat loss responses [
         <a href="#rid8">
          8
         </a>
         ]. Central adrenergic pathways may contribute to the reaction, as evidenced by the relief that many women gain from use of an alpha-2 agonist [
         <a href="#rid1">
          1,4
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h3">
          Emotional flushing
         </span>
         <span class="headingEndMark">
          —
         </span>
         Emotional flushing may be a significant source of discomfort for a patient and is more common in women than men. The exact etiology of the heightened vascular response has not been determined.
        </p>
        <p>
         It has been suggested that blushers are particularly concerned with how others perceive them [
         <a href="#rid10">
          10
         </a>
         ]. These patients often exhibit other heightened physiological reactions to stress, including palpitations, dry mouth, and a sense of cognitive dysfunction. The flushing reaction may be triggered by even minor healthy emotional responses.
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h3">
          Neurologic disorders
         </span>
         <span class="headingEndMark">
          —
         </span>
         Lesions that disturb autonomic function anywhere along the nervous system can lead to flushing. Neurologic disorders that may cause autonomic instability and flushing include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Tumors or masses that compress the third ventricle.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Diencephalic autonomic epilepsy – Generalized seizures accompanied by sympathetic and parasympathetic discharge that results in sweating, flushing, piloerection, salivation, tachycardia, and hypertension.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cluster headache – Characterized by hemifacial sweating, lacrimation, rhinorrhea, and Horner syndrome [
         <a href="#rid11">
          11
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3326.html" rel="external">
          "Cluster headache: Epidemiology, clinical features, and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Spinal cord injuries – Cause autonomic hyperreflexia [
         <a href="#rid12">
          12
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4839.html" rel="external">
          "Chronic complications of spinal cord injury and disease", section on 'Thermoregulatory dysfunction'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Parkinson disease. (See
         <a class="medical medical_review" href="/z/d/html/4903.html" rel="external">
          "Clinical manifestations of Parkinson disease", section on 'Autonomic dysfunction'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Multiple sclerosis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Autonomic hyperreflexia and orthostatic hypotension [
         <a href="#rid2">
          2
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5103.html" rel="external">
          "Mechanisms, causes, and evaluation of orthostatic hypotension", section on 'Baroreflex dysfunction'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Auriculotemporal (Frey) syndrome – Recurrent episodes of gustatory flushing and/or sweating in the cutaneous distribution of the auriculotemporal nerve. This is believed to result from misdirection of regenerated parasympathetic nerve fibers [
         <a href="#rid2">
          2
         </a>
         ] and can occur after parotid surgery or injury, perinatal birth injury, or facial trauma in childhood [
         <a href="#rid13">
          13
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5567.html" rel="external">
          "Primary focal hyperhidrosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Trigeminal neuralgia and migraine headache – May cause unilateral flushing, described as "antidromic sensorineural flushing" [
         <a href="#rid1">
          1
         </a>
         ]. This is mediated by a nonclassic autonomic vasodilator system that originates in the brainstem and is not associated with eccrine sweat gland activation.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Harlequin syndrome – Rare autonomic disorder involving unilateral hyperhidrosis and flushing of the head and neck. It is felt to be secondary to compression or a lesion of the sympathetic regulatory neurons. Flushing is often brought on by exercise or heat [
         <a href="#rid14">
          14
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h2">
          Vasodilator mediated flushing
         </span>
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h3">
          Rosacea
         </span>
         <span class="headingEndMark">
          —
         </span>
         Acne rosacea is a common inflammatory dermatologic disorder primarily affecting the face. The typical age of onset is between age 40 and 60, though earlier onset is not uncommon. (See
         <a class="medical medical_review" href="/z/d/html/13621.html" rel="external">
          "Rosacea: Pathogenesis, clinical features, and diagnosis"
         </a>
         .)
        </p>
        <p>
         Rosacea characteristically is associated with telangiectasias as well as papules and pustules. Flushing is one of the earliest reported symptoms, and some have suggested that frequent flushing may be part of the pathogenesis of the disorder [
         <a href="#rid5">
          5
         </a>
         ]. Flushing may be stimulated by emotion, heat or cold, exercise, spicy or hot foods, and alcohol. Patients often complain of a burning sensation. Xerosis, edema, and plaque formation may all occur.
        </p>
        <p>
         Diagnosis is purely clinical, with persistent facial erythema lasting greater than three months and frequent flushing episodes.
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h3">
          Medications
         </span>
         <span class="headingEndMark">
          —
         </span>
         Many medications cause flushing [
         <a href="#rid2">
          2
         </a>
         ]. The mechanisms responsible include vasodilation, increased prostacyclin synthesis, release of mast cell mediators, and release of other vasoactive mediators [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Vasodilators
         </strong>
         - Vasodilators, including calcium channel blockers,
         <a class="drug drug_general" data-topicid="9706" href="/z/d/drug information/9706.html" rel="external">
          nitroglycerin
         </a>
         , and phosphodiesterase 5 inhibitors (
         <a class="drug drug_general" data-topicid="9643" href="/z/d/drug information/9643.html" rel="external">
          sildenafil
         </a>
         ,
         <a class="drug drug_general" data-topicid="10172" href="/z/d/drug information/10172.html" rel="external">
          vardenafil
         </a>
         , and
         <a class="drug drug_general" data-topicid="10108" href="/z/d/drug information/10108.html" rel="external">
          tadalafil
         </a>
         ), are the most common medications associated with flushing.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Among calcium channel blockers, dihydropyridine agents (eg,
         <a class="drug drug_general" data-topicid="9700" href="/z/d/drug information/9700.html" rel="external">
          nifedipine
         </a>
         ,
         <a class="drug drug_general" data-topicid="9703" href="/z/d/drug information/9703.html" rel="external">
          nisoldipine
         </a>
         ,
         <a class="drug drug_general" data-topicid="8627" href="/z/d/drug information/8627.html" rel="external">
          amlodipine
         </a>
         ) are more commonly associated with flushing than nondihydropyridine agents (eg,
         <a class="drug drug_general" data-topicid="9365" href="/z/d/drug information/9365.html" rel="external">
          diltiazem
         </a>
         and
         <a class="drug drug_general" data-topicid="10043" href="/z/d/drug information/10043.html" rel="external">
          verapamil
         </a>
         ). Among the dihydropyridine agents, nifedipine is the most commonly associated with flushing [
         <a href="#rid15">
          15
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3832.html" rel="external">
          "Major side effects and safety of calcium channel blockers"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Nicotinic acid
         </strong>
         - Flushing associated with nicotinic acid therapy is caused by an increase in prostacyclin, which is a potent vasodilator. The flushing response is antagonized by concomitant
         <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">
          aspirin
         </a>
         administration. Newer slow-release formulations tend to mitigate this effect. (See
         <a class="medical medical_review" href="/z/d/html/4562.html" rel="external">
          "Low-density lipoprotein cholesterol lowering with drugs other than statins and PCSK9 inhibitors"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The selective prostaglandin D2 receptor antagonist laropiprant has been shown to decrease flushing associated with extended-release
         <a class="drug drug_general" data-topicid="9695" href="/z/d/drug information/9695.html" rel="external">
          niacin
         </a>
         , but long-term safety data are absent, and it is not clear that the benefit is greater than that achieved by
         <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">
          aspirin
         </a>
         [
         <a href="#rid16">
          16
         </a>
         ]. This medication is not available in the United States.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Other medications
         </strong>
         - Other medications that may produce flushing include [
         <a href="#rid2">
          2
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Antihypertensives – Beta-blockers and angiotensin-converting enzyme (ACE) inhibitors
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Hormonal therapies – Calcitonin, calcitonin gene-related peptide, thyrotropin-releasing hormone,
         <a class="drug drug_general" data-topicid="9549" href="/z/d/drug information/9549.html" rel="external">
          leuprolide
         </a>
         ,
         <a class="drug drug_general" data-topicid="9295" href="/z/d/drug information/9295.html" rel="external">
          cyproterone acetate
         </a>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Glucocorticoids – High-dose intravenous
         <a class="drug drug_general" data-topicid="9639" href="/z/d/drug information/9639.html" rel="external">
          methylprednisolone
         </a>
         , oral
         <a class="drug drug_general" data-topicid="10015" href="/z/d/drug information/10015.html" rel="external">
          triamcinolone
         </a>
         , intrasynovial triamcinolone
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Antimicrobials –
         <a class="drug drug_general" data-topicid="10037" href="/z/d/drug information/10037.html" rel="external">
          Vancomycin
         </a>
         and amphotericin B (see
         <a class="medical medical_review" href="/z/d/html/2083.html" rel="external">
          "Vancomycin hypersensitivity", section on 'Vancomycin infusion reaction'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Chemotherapy agents –
         <a class="drug drug_general" data-topicid="9217" href="/z/d/drug information/9217.html" rel="external">
          Cyclosporine
         </a>
         ,
         <a class="drug drug_general" data-topicid="9391" href="/z/d/drug information/9391.html" rel="external">
          doxorubicin
         </a>
         ,
         <a class="drug drug_general" data-topicid="9271" href="/z/d/drug information/9271.html" rel="external">
          cisplatin
         </a>
         , interferon alfa-2,
         <a class="drug drug_general" data-topicid="9972" href="/z/d/drug information/9972.html" rel="external">
          tamoxifen
         </a>
         , mithramycin,
         <a class="drug drug_general" data-topicid="9316" href="/z/d/drug information/9316.html" rel="external">
          dacarbazine
         </a>
         , and
         <a class="drug drug_general" data-topicid="8471" href="/z/d/drug information/8471.html" rel="external">
          flutamide
         </a>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Opiates and related drugs –
         <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">
          Morphine
         </a>
         and other narcotics, enkephalin analogs
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <a class="drug drug_general" data-topicid="9642" href="/z/d/drug information/9642.html" rel="external">
          Metoclopramide
         </a>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Gold
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Induction of anesthesia (especially the combination of
         <a class="drug drug_general" data-topicid="8992" href="/z/d/drug information/8992.html" rel="external">
          isoflurane
         </a>
         and
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          fentanyl
         </a>
         ) [
         <a href="#rid17">
          17
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Contrast media
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Nonsteroidal antiinflammatory drugs (NSAIDs)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <a class="drug drug_general" data-topicid="9164" href="/z/d/drug information/9164.html" rel="external">
          Bromocriptine
         </a>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Catecholamines
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         There are also several medications that can cause flushing when taken in combination with alcohol. (See
         <a class="local">
          'Alcohol'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h3">
          Food ingestion
         </span>
         <span class="headingEndMark">
          —
         </span>
         A variety of foods or their additives may be responsible for flushing. Spicy foods are often implicated, particularly those containing
         <a class="drug drug_general" data-topicid="8840" href="/z/d/drug information/8840.html" rel="external">
          capsaicin
         </a>
         , which is derived from red peppers [
         <a href="#rid1">
          1
         </a>
         ]. Other examples include foods containing sodium nitrate (eg, cured meats) and sulfites (used to maintain freshness).
        </p>
        <p>
         Certain toxins can produce a flushing reaction, believed to be mediated by histamine [
         <a href="#rid1">
          1
         </a>
         ]. Scombroid fish poisoning is commonly associated with flushing and also causes headache, nausea, oral burning, sweating, and diarrhea. Ciguatera fish poisoning is characterized by abdominal pain, nausea and vomiting, diarrhea, flushing, pruritus, dysesthesias, and muscle weakness. (See
         <a class="medical medical_review" href="/z/d/html/2745.html" rel="external">
          "Overview of shellfish, pufferfish, and other marine toxin poisoning"
         </a>
         .)
        </p>
        <p>
         Monosodium glutamate (MSG) in Chinese food has long been purported to cause a flushing reaction as part of the "MSG syndrome." However, randomized placebo-controlled studies raise questions as to whether MSG reproducibly causes symptoms in most individuals who believe they react to this additive [
         <a href="#rid18">
          18,19
         </a>
         ]. When MSG is ingested in large doses, however, it causes an increase in an acetylcholine-like substance that may result in flushing in susceptible individuals [
         <a href="#rid1">
          1
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2405.html" rel="external">
          "Allergic and asthmatic reactions to food additives"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H17">
         <span class="h3">
          Alcohol
         </span>
         <span class="headingEndMark">
          —
         </span>
         Alcohol (ethanol) ingestion may cause flushing by direct vasodilation of blood vessels in the skin, either due to the alcohol or its metabolite, acetaldehyde. Acetaldehyde triggers catecholamine release from the adrenal medulla and sympathetic nerves [
         <a href="#rid20">
          20
         </a>
         ]. Further, some alcoholic beverages such as wine contain vasoactive substances (such as tyramine, histamine, and sulfites) that contribute to the flushing response [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
         Alcohol is oxidized to acetaldehyde in the liver by alcohol dehydrogenase (ADH), and the rate of this reaction is a key factor in determining whether flushing will occur [
         <a href="#rid21">
          21
         </a>
         ]. In addition, aldehyde dehydrogenase (ALDH) enzymes are also involved in alcohol metabolism and are responsible for the break down acetaldehyde; ALDH-2 deficiency, seen frequently in individuals of Asian descent, results in severe flushing after alcohol ingestion due to a buildup of acetaldehyde [
         <a href="#rid22">
          22
         </a>
         ]. Of note, several studies have suggested that such polymorphisms in ALDH may increase an individual’s susceptibility to esophageal cancer as well as oropharyngeal cancer [
         <a href="#rid23">
          23,24
         </a>
         ].
        </p>
        <p>
         Many medications, when combined with alcohol, can intensify the flushing response. Disulfiram inhibits ADH and may cause severe flushing, nausea, vomiting, and hypotension. Co-administration of sulfonylurea medication (particularly chlorpropamide, where available) with alcohol is well known to cause flushing that typically begins around the eyes and spreads to the forehead [
         <a href="#rid25">
          25
         </a>
         ]. Other medications that may cause flushing with concomitant alcohol administration include
         <a class="drug drug_general" data-topicid="9646" href="/z/d/drug information/9646.html" rel="external">
          metronidazole
         </a>
         ,
         <a class="drug drug_general" data-topicid="8589" href="/z/d/drug information/8589.html" rel="external">
          ketoconazole
         </a>
         ,
         <a class="drug drug_general" data-topicid="8502" href="/z/d/drug information/8502.html" rel="external">
          griseofulvin
         </a>
         , cephalosporins, antimalarials [
         <a href="#rid2">
          2
         </a>
         ], and topical calcineurin inhibitors [
         <a href="#rid26">
          26
         </a>
         ].
        </p>
        <p>
         Additionally, patients with underlying rhinitis or aspirin-sensitive respiratory disease may experience flushing and severe nasal congestion when drinking alcohol. (See
         <a class="medical medical_review" href="/z/d/html/7533.html" rel="external">
          "An overview of rhinitis", section on 'Nonallergic rhinitis'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/520.html" rel="external">
          "Aspirin-exacerbated respiratory disease", section on 'Reactions to alcoholic beverages'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h3">
          Carcinoid syndrome
         </span>
         <span class="headingEndMark">
          —
         </span>
         The classic carcinoid syndrome is characterized by flushing and secretory diarrhea; additional symptoms may include profuse sweating, abdominal pain, and bronchospasm. Patients with longstanding carcinoid syndrome may develop valvular heart disease (especially right-sided) and facial telangiectasias. However, only a small subset of patients with carcinoid tumors will experience symptoms of carcinoid syndrome (see
         <a class="medical medical_review" href="/z/d/html/2614.html" rel="external">
          "Clinical features of carcinoid syndrome"
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The carcinoid syndrome is primarily associated with metastatic tumors originating in the distal small intestine and proximal colon (midgut). Since the liver normally inactivates these hormones, there needs to be enough tumor burden downstream of normally functioning hepatic tissue for the mediators to enter the systemic circulation and cause symptoms [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The typical flush associated with midgut carcinoids (jejunum, ileum, cecum, appendix) begins suddenly and lasts from 30 seconds to as long as 30 minutes. It primarily involves the face, neck, and upper chest, which become red to violaceous or purple, and is associated with a mild burning sensation (
         <a class="graphic graphic_picture graphicRef55493" href="/z/d/graphic/55493.html" rel="external">
          picture 1
         </a>
         ). Patients often develop a drop in blood pressure as well as tachycardia during a typical flushing episode.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         By contrast, bronchial, gastric, appendiceal and rectal carcinoid tumors (ie, those arising from the foregut and hindgut) can produce the carcinoid syndrome in the absence of metastatic disease because of their direct access to the systemic circulation, but this is rare overall (
         <a class="graphic graphic_table graphicRef56015" href="/z/d/graphic/56015.html" rel="external">
          table 2
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         When they occur, the flushes associated with gastric carcinoid tumors are atypical and tend to be red-brown hue, patchy, sharply demarcated, and serpiginous; they are also intensely pruritic. (See
         <a class="medical medical_review" href="/z/d/html/2614.html" rel="external">
          "Clinical features of carcinoid syndrome", section on 'Gastric NET variant syndrome'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In patients with the bronchial carcinoid variant, the flushes can be very severe and prolonged, lasting hours to days [
         <a href="#rid27">
          27
         </a>
         ]. They may be associated with disorientation, anxiety, and tremor. (See
         <a class="medical medical_review" href="/z/d/html/2614.html" rel="external">
          "Clinical features of carcinoid syndrome", section on 'Lung NET variant syndrome'
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         A variety of stimuli may trigger flushing in patients with carcinoid syndrome, including alcohol, chocolate, and ingestion of beef. It is postulated that alcohol and chocolate may release a catecholamine with direct activity on the tumor. The secretion of gastrin may also play a role, particularly in tumors of stomach or foregut origin. Alcohol and beef consumption are known to enhance gastrin secretion, which is one proposed mechanism for their mediating a carcinoid flush [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
         Potential flushing mediators include substance P, histamine, kallikrein, and kinins, although it is not absolutely clear which vasoactive hormone is responsible for symptoms. (See
         <a class="medical medical_review" href="/z/d/html/2614.html" rel="external">
          "Clinical features of carcinoid syndrome", section on 'Pathophysiology'
         </a>
         .)
        </p>
        <p>
         The diagnosis of carcinoid syndrome may be made by measurement of 24-hour urine for 5-hydroxyindoleoacetic acid (5-HIAA), a metabolite of serotonin. Diagnosis and tumor localization are discussed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/2622.html" rel="external">
          "Diagnosis of carcinoid syndrome and tumor localization"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H19">
         <span class="h3">
          Mastocytosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Mastocytosis is a rare disorder of mast cell proliferation leading to tissue infiltration. (See
         <a class="medical medical_review" href="/z/d/html/4784.html" rel="external">
          "Mastocytosis (cutaneous and systemic) in adults: Epidemiology, pathogenesis, clinical manifestations, and diagnosis"
         </a>
         .)
        </p>
        <p>
         Mastocytosis in the pediatric population is typically associated with a skin rash characterized by red-brown papules, macules, or plaques that become urticarial with topical pressure (Darier sign) (
         <a class="graphic graphic_picture graphicRef97908" href="/z/d/graphic/97908.html" rel="external">
          picture 2
         </a>
         ) [
         <a href="#rid28">
          28
         </a>
         ]. Systemic symptoms and abnormalities in the peripheral blood smear are more common in adults. Systemic symptoms are caused by the release of mast cell mediators such as histamine and prostaglandin, which cause vasodilation, flushing, hypotension, tachycardia, and anaphylaxis. Patients may also have abdominal cramping, diarrhea, nausea, vomiting, and fever.
        </p>
        <p>
         Systemic symptoms may be triggered by narcotic analgesics, as well as by agents that trigger allergic reactions such as intravenous contrast [
         <a href="#rid4">
          4
         </a>
         ]. Other known precipitants include anesthetic agents,
         <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">
          aspirin
         </a>
         , and other NSAIDs [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
         Two related disorders (ie, idiopathic and monoclonal mast cell activation syndromes) are felt to be distinct from mastocytosis. Patients with these disorders typically present with abdominal pain, dermatographism, and flushing, and they may also report headache, diarrhea, and memory or concentration difficulties. (See
         <a class="medical medical_review" href="/z/d/html/15715.html" rel="external">
          "Mast cell disorders: An overview"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H20">
         <span class="h3">
          Pheochromocytoma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pheochromocytoma is a neoplasia of chromaffin cells. The tumor is typically derived from the adrenal medulla and is associated with a release of catecholamines episodically into the systemic circulation.
        </p>
        <p>
         Headaches, sweating, and tachycardia and hypertension are common; 60 percent of patients have sustained hypertension or labile blood pressure, and 40 percent experience blood pressure elevation only during attacks [
         <a href="#rid2">
          2
         </a>
         ]. Patients may experience either pallor or flushing, though flushing characteristically occurs following, rather than during, a typical attack. A feeling of apprehension is not uncommon, and patients often experience nausea, vomiting, and chest or abdominal pain. Episodes are paroxysmal in nature and last between minutes to hours.
        </p>
        <p>
         Catecholamine-induced flushing is felt to be regulated by innervation of sympathetic vasodilator fibers of the face, as well as related to increased cardiac output. Diagnosis is made by measuring urinary catecholamine and fractionated metanephrine levels. The clinical presentation and evaluation of pheochromocytoma is reviewed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/130.html" rel="external">
          "Clinical presentation and diagnosis of pheochromocytoma"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H21">
         <span class="h3">
          Medullary thyroid carcinoma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Medullary thyroid carcinoma is a malignant tumor of parafollicular thyroid cells. Tumor cells produce calcitonin, as well as biogenic amines, adrenocorticotropic hormone (ACTH), and corticotropin-releasing hormone [
         <a href="#rid7">
          7
         </a>
         ]. Presentation typically involves facial and upper-extremity flushing, as well as telangiectasias. (See
         <a class="medical medical_review" href="/z/d/html/7848.html" rel="external">
          "Medullary thyroid cancer: Clinical manifestations, diagnosis, and staging"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H22">
         <span class="h3">
          Serotonin syndrome
         </span>
         <span class="headingEndMark">
          —
         </span>
         The serotonin syndrome, associated with increased serotonergic activity in the central nervous system, is most often related to medication side effects and interactions. It is characterized by mental status changes, autonomic hyperreactivity, and neuromuscular hyperreactivity. Diaphoresis and hyperthermia are characteristic autonomic manifestations that may present as flushing. (See
         <a class="medical medical_review" href="/z/d/html/301.html" rel="external">
          "Serotonin syndrome (serotonin toxicity)"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H23">
         <span class="h3">
          Anaphylaxis
         </span>
         <span class="headingEndMark">
          —
         </span>
         It is important to consider anaphylaxis in the differential diagnosis of flushing. Flushing occurs commonly with anaphylaxis but generally in conjunction with other symptoms such as hypotension, stridor, hives, and abdominal pain; flushing in isolation is rare [
         <a href="#rid2">
          2
         </a>
         ]. Flushing is seen in almost 50 percent of anaphylactic allergic reactions to medications [
         <a href="#rid29">
          29
         </a>
         ].
        </p>
        <p>
         Flushing is caused by the release of mast cell as well as basophil vasoactive substances into the circulation. Diagnosis is typically based on clinical presentation, and prompt treatment is imperative. (See
         <a class="medical medical_review" href="/z/d/html/106778.html" rel="external">
          "Anaphylaxis: Acute diagnosis", section on 'Symptoms and signs'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H24">
         <span class="h3">
          Pancreatic tumor/VIPoma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Vasoactive intestinal polypeptide (VIP) tumors are non-beta islet cell neoplasms that secrete VIP, prostaglandins, gastric inhibitory peptides, and pancreatic peptides [
         <a href="#rid2">
          2
         </a>
         ]. Typical presentation includes watery diarrhea, hypokalemia, and achlorhydria (WDHA syndrome) [
         <a href="#rid7">
          7
         </a>
         ]. Flushing occurs in 20 percent of patients and is attributable to the vasodilator action of VIP. (See
         <a class="medical medical_review" href="/z/d/html/2610.html" rel="external">
          "VIPoma: Clinical manifestations, diagnosis, and management"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H26">
         <span class="h3">
          Other
         </span>
         <span class="headingEndMark">
          —
         </span>
         A number of less common causes of flushing should be considered in a broad differential diagnosis. These include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Dumping syndrome or short-gut syndrome – Tachycardia, flushing, sweating, dizziness, and hypotension related to rapid gut transit.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Sarcoidosis – Associated with facial flushing due to vasodilation caused by granuloma infiltration of blood vessels in the skin, especially in the lupus pernio variant. (See
         <a class="medical medical_review" href="/z/d/html/4353.html" rel="external">
          "Clinical manifestations and diagnosis of sarcoidosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hyperthyroidism. (See
         <a class="medical medical_review" href="/z/d/html/7833.html" rel="external">
          "Overview of the clinical manifestations of hyperthyroidism in adults", section on 'Skin'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Bronchogenic carcinoma.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Androgen deficiency in men.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Renal cell carcinoma – Renal cell carcinoma most often presents with hematuria. The classic triad of gross hematuria, palpable abdominal mass, and flank pain is present in less than 10 percent of cases. Patients may also have fatigue, weight loss, fever, and anemia. Flushing, when it occurs, is felt to be due to the production of gonadotropin-like hormones from the tumor that cause a downregulation of the pituitary gland. (See
         <a class="medical medical_review" href="/z/d/html/2983.html" rel="external">
          "Clinical manifestations, evaluation, and staging of renal cell carcinoma"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Superior vena cava syndrome [
         <a href="#rid30">
          30
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Additionally, other conditions that cause facial erythema may be mistaken for a flushing reaction. Conditions to be considered are:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Mitral stenosis – Can cause a chronic malar flush associated with cyanosis [
         <a href="#rid4">
          4
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Systemic lupus erythematosus — The classic malar or "butterfly rash" over the cheeks and nose may be confused with flushing
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Photosensitivity reactions
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H27">
         <span class="h1">
          EVALUATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         A summary of an approach to evaluating a patient with flushing is presented in an algorithm (
         <a class="graphic graphic_algorithm graphicRef68454" href="/z/d/graphic/68454.html" rel="external">
          algorithm 1
         </a>
         ).
        </p>
        <p>
         A detailed history and physical examination are important in evaluating the patient with flushing. The presence of sweating associated with flushing suggests an autonomic mediated etiology of flushing and distinguishes this from a direct vasodilator etiology.
        </p>
        <p>
         Patients should be advised to keep a diary of flushing reactions for two weeks, recording associations with food or medication, exertion, or emotional stress as well as symptoms including headache, bronchospasm, abdominal pain, diarrhea, and urticaria [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
         Most systemic disorders that include flushing are distinguished by typical associated symptoms. When history and physical do not yield a probable diagnosis, the patient should undergo assessment for carcinoid syndrome, mastocytosis, and pheochromocytoma, as these are the most common systemic disorders to cause flushing. Initial laboratory evaluation should include a complete blood count and liver function tests, a 24-hour urine for 5-hydroxyindoleoacetic acid (5-HIAA; carcinoid syndrome), serum tryptase (mastocytosis), and a 24-hour urine for catecholamines and fractionated metanephrines (pheochromocytoma). (See
         <a class="medical medical_review" href="/z/d/html/2622.html" rel="external">
          "Diagnosis of carcinoid syndrome and tumor localization"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4784.html" rel="external">
          "Mastocytosis (cutaneous and systemic) in adults: Epidemiology, pathogenesis, clinical manifestations, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/130.html" rel="external">
          "Clinical presentation and diagnosis of pheochromocytoma"
         </a>
         .)
        </p>
        <p>
         If initial studies are negative, referral to an endocrinologist is warranted to continue evaluation for etiologies such as a VIPoma, medullary thyroid carcinoma, and other conditions as noted above.
        </p>
        <p class="headingAnchor" id="H28">
         <span class="h1">
          TREATMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         Treatment is typically tailored to the underlying condition or predisposing factor. Flushing that is a consequence of an exogenous agent is readily treated by removal of the identified offending agent.
        </p>
        <p>
         Anaphylaxis must be immediately recognized and treated. Patients with flushing as a consequence of a systemic illness should be treated appropriately for the underlying condition. (See
         <a class="medical medical_review" href="/z/d/html/392.html" rel="external">
          "Anaphylaxis: Emergency treatment"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2615.html" rel="external">
          "Staging, treatment, and post-treatment surveillance of non-metastatic, well-differentiated gastrointestinal tract neuroendocrine (carcinoid) tumors"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4787.html" rel="external">
          "Advanced systemic mastocytosis: Management and prognosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/142.html" rel="external">
          "Treatment of pheochromocytoma in adults"
         </a>
         .)
        </p>
        <p>
         Other specific conditions may respond to tailored treatment for flushing. For example:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Menopausal-related hot flashes may respond to a variety of agents [
         <a href="#rid31">
          31,32
         </a>
         ]; the treatment in reviewed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/7390.html" rel="external">
          "Menopausal hot flashes", section on 'Management'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Flushing related to nicotinic acid can be prevented by administration of
         <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">
          aspirin
         </a>
         prior to a dose of nicotinic acid and by use of longer-acting formulations of nicotinic acid. (See
         <a class="medical medical_review" href="/z/d/html/4562.html" rel="external">
          "Low-density lipoprotein cholesterol lowering with drugs other than statins and PCSK9 inhibitors", section on 'Side effects'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Alcohol-induced flushing can be prevented by avoiding alcohol consumption. In addition, in a trial including East Asian participants, application of topical
         <a class="drug drug_general" data-topicid="9163" href="/z/d/drug information/9163.html" rel="external">
          brimonidine
         </a>
         (0.33% gel) to the face 30 minutes prior to alcohol consumption decreased facial flushing [
         <a href="#rid33">
          33
         </a>
         ]. Although
         <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">
          aspirin
         </a>
         and antihistamines have also been reported to prevent flushing, this is not supported by high-quality data [
         <a href="#rid34">
          34-37
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients may develop tolerance to calcium channel blocker flushing over time.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Flushing associated with rosacea has been treated with only minimal success [
         <a href="#rid38">
          38,39
         </a>
         ] and is reviewed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/16632.html" rel="external">
          "Management of rosacea", section on 'Avoidance of flushing'
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         For most benign etiologies, there are no agents that easily and readily eliminate the flushing response. Emotional flushing or blushing may respond to the use of a nonselective beta blocker, particularly when associated with other prominent sympathetic nervous system features such as tachycardia, palpitations, and dry mouth [
         <a href="#rid1">
          1
         </a>
         ]. Individuals who are predisposed to blushing secondary to skin type may find that use of cosmetics with a green tint can offset the redness [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
         Botulinum toxin A has been used with success to treat neck and anterior chest wall flushing [
         <a href="#rid40">
          40
         </a>
         ]. Endoscopic transthoracic sympathectomy has been reported to have short-term effectiveness for severe cases of flushing associated with social phobia [
         <a href="#rid41">
          41
         </a>
         ]. The potential side effects of such procedures must be weighed against possible benefits, and in general we do not recommend either botulinum toxin or sympathectomy for management of flushing.
        </p>
        <p class="headingAnchor" id="H29422495">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topic (see
         <a class="medical medical_basics" href="/z/d/html/16652.html" rel="external">
          "Patient education: Rosacea (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H29">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Etiologies
         </strong>
         – The most common etiologies of flushing are fever, hyperthermia, menopause, emotional blushing, or rosacea. Flushing may be categorized as autonomic-mediated or vasodilator-mediated flushing. Autonomic flushing syndromes include thermoregulatory flushing, emotional flushing, and flushing related to a central nervous system disorder. Vasodilator flushing may be caused by exogenous agents (drugs, alcohol, food) or endogenous hormones resulting from systemic disease (
         <a class="graphic graphic_table graphicRef53013" href="/z/d/graphic/53013.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="local">
          'Etiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Evaluation: History and physical examination
         </strong>
         – A thorough history and physical is important. Patients should maintain a diary for at least two weeks that documents each flushing episode along with associated activity, food intake, emotional state, and medication use (
         <a class="graphic graphic_algorithm graphicRef68454" href="/z/d/graphic/68454.html" rel="external">
          algorithm 1
         </a>
         ). Although many conditions that are associated with flushing have nonspecific or no physical examination findings, the presence of other skin lesions, hypertension, thyroid nodule, or abdominal mass may suggest specific etiologies. (See
         <a class="local">
          'Evaluation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Laboratory evaluation when cause remains uncertain
         </strong>
         – Most systemic disorders that include flushing are distinguished by typical associated symptoms. When history and physical do not yield a probable diagnosis, the patient should undergo assessment for carcinoid syndrome, mastocytosis, and pheochromocytoma, as these are the most common systemic disorders to cause flushing. Initial laboratory evaluation should include a complete blood count and liver function tests, and a 24-hour urine for 5-hydroxyindoleoacetic acid (5-HIAA; carcinoid syndrome), serum tryptase (mastocytosis), and catecholamines and fractionated metanephrines (pheochromocytoma) (
         <a class="graphic graphic_algorithm graphicRef68454" href="/z/d/graphic/68454.html" rel="external">
          algorithm 1
         </a>
         ). (See
         <a class="local">
          'Evaluation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Treat underlying cause
         </strong>
         – Treatment is tailored to the underlying condition or predisposing factor. Avoidance of hot beverages, spicy foods, cured meats, and alcohol may be helpful for those individuals who are predisposed to flushing episodes. (See
         <a class="local">
          'Treatment'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Wilkin JK. The red face: flushing disorders. Clin Dermatol 1993; 11:211.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Izikson L, English JC 3rd, Zirwas MJ. The flushing patient: differential diagnosis, workup, and treatment. J Am Acad Dermatol 2006; 55:193.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Robson KJ, Piette WW. Cutaneous manifestations of systemic diseases. Med Clin North Am 1998; 82:1359.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ray D, Williams G. Pathophysiological causes and clinical significance of flushing. Br J Hosp Med 1993; 50:594.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wilkin JK. Flushing reactions: consequences and mechanisms. Ann Intern Med 1981; 95:468.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wilkin JK. Oral thermal-induced flushing in erythematotelangiectatic rosacea. J Invest Dermatol 1981; 76:15.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mohyi D, Tabassi K, Simon J. Differential diagnosis of hot flashes. Maturitas 1997; 27:203.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kronenberg F. Hot flashes: epidemiology and physiology. Ann N Y Acad Sci 1990; 592:52.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aldrich LB, Moattari AR, Vinik AI. Distinguishing features of idiopathic flushing and carcinoid syndrome. Arch Intern Med 1988; 148:2614.
          </a>
         </li>
         <li class="breakAll">
          Edelmann R. Coping with blushing, Sheldon Press, London 1990.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Freeman R, Waldorf HA, Dover JS. Autonomic neurodermatology (Part II): Disorders of sweating and flushing. Semin Neurol 1992; 12:394.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khanna K, Theologis AA, Tay B. Autonomic dysreflexia caused by cervical stenosis. Spinal Cord Ser Cases 2017; 3:17102.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kaddu S, Smolle J, Komericki P, Kerl H. Auriculotemporal (Frey) syndrome in late childhood: an unusual variant presenting as gustatory flushing mimicking food allergy. Pediatr Dermatol 2000; 17:126.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tascilar N, Tekin NS, Erdem Z, et al. Unnoticed dysautonomic syndrome of the face: Harlequin syndrome. Auton Neurosci 2007; 137:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ioulios P, Charalampos M, Efrossini T. The spectrum of cutaneous reactions associated with calcium antagonists: a review of the literature and the possible etiopathogenic mechanisms. Dermatol Online J 2003; 9:6.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maccubbin D, Koren MJ, Davidson M, et al. Flushing profile of extended-release niacin/laropiprant versus gradually titrated niacin extended-release in patients with dyslipidemia with and without ischemic cardiovascular disease. Am J Cardiol 2009; 104:74.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Olday J, Currie E, Drummond GB. The incidence of flushing on induction of anaesthesia in patients who blush easily. Anaesthesia 2003; 58:275.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wilkin JK. Does monosodium glutamate cause flushing (or merely "glutamania")? J Am Acad Dermatol 1986; 15:225.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Geha RS, Beiser A, Ren C, et al. Review of alleged reaction to monosodium glutamate and outcome of a multicenter double-blind placebo-controlled study. J Nutr 2000; 130:1058S.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chao HM. Alcohol and the mystique of flushing. Alcohol Clin Exp Res 1995; 19:104.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eriksson CJ, Fukunaga T, Sarkola T, et al. Functional relevance of human adh polymorphism. Alcohol Clin Exp Res 2001; 25:157S.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oroszi G, Goldman D. Alcoholism: genes and mechanisms. Pharmacogenomics 2004; 5:1037.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morita M, Kumashiro R, Kubo N, et al. Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: epidemiology, clinical findings, and prevention. Int J Clin Oncol 2010; 15:126.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Matejcic M, Gunter MJ, Ferrari P. Alcohol metabolism and oesophageal cancer: a systematic review of the evidence. Carcinogenesis 2017; 38:859.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fellner MJ, Ledesma GN. The red face: drugs, chemicals and other causes. Clin Dermatol 1993; 11:315.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ogunleye T, James WD. Ethanol-induced flushing with topical pimecrolimus use. Dermatitis 2008; 19:E1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Melmon KL, Sjoerdsma A, Mason DT. Distinctive clinical and therapeutic aspects of the syndrome associated with bronchial carcinoid tumors. Am J Med 1965; 39:568.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Soter NA. Mastocytosis and the skin. Hematol Oncol Clin North Am 2000; 14:537.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aaronson DW. Flushing as a symptom of anaphylaxis. J Allergy Clin Immunol 1999; 103:715.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Plunkett M, Wethasinghe J, O'Donoghue B, et al. Facial flushing on upper limb exertion: a rare presentation of superior vena cava obstruction. Respirol Case Rep 2018; 6:e00297.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hammar M, Berg G. Clonidine in the treatment of menopausal flushing. A review of clinical studies. Acta Obstet Gynecol Scand Suppl 1985; 132:29.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nelson HD, Vesco KK, Haney E, et al. Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis. JAMA 2006; 295:2057.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yu WY, Lu B, Tan D, et al. Effect of Topical Brimonidine on Alcohol-Induced Flushing in Asian Individuals: A Randomized Clinical Trial. JAMA Dermatol 2020; 156:182.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Truitt EB Jr, Gaynor CR, Mehl DL. Aspirin attenuation of alcohol-induced flushing and intoxication in Oriental and Occidental subjects. Alcohol Alcohol Suppl 1987; 1:595.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tan OT, Stafford TJ, Sarkany I, et al. Suppression of alcohol-induced flushing by a combination of H1 and H2 histamine antagonists. Br J Dermatol 1982; 107:647.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miller NS, Goodwin DW, Jones FC, et al. Combined antihistamine antagonism of the flushing reaction to alcohol. Alcohol Alcohol Suppl 1987; 1:583.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chrostek L, Cylwik B, Szmitkowski M. [Interactions between ethanol and histamine]. Pol Merkur Lekarski 2007; 23:225.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wilkin JK. Effect of subdepressor clonidine on flushing reactions in rosacea. Change in malar thermal circulation index during provoked flushing reactions. Arch Dermatol 1983; 119:211.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wilkin JK. Effect of nadolol on flushing reactions in rosacea. J Am Acad Dermatol 1989; 20:202.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sterodimas A, Nicolaou M, Paes TR. Successful use of Botulinum toxin-A for the treatment of neck and anterior chest wall flushing. Clin Exp Dermatol 2003; 28:592.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Drummond PD. A caution about surgical treatment for facial blushing. Br J Dermatol 2000; 142:194.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 2782 Version 44.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8348435" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : The red face: flushing disorders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16844500" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : The flushing patient: differential diagnosis, workup, and treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9889752" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Cutaneous manifestations of systemic diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8293240" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Pathophysiological causes and clinical significance of flushing.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6169300" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Flushing reactions: consequences and mechanisms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6450809" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Oral thermal-induced flushing in erythematotelangiectatic rosacea.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9288692" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Differential diagnosis of hot flashes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2197954" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Hot flashes: epidemiology and physiology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2461688" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Distinguishing features of idiopathic flushing and carcinoid syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2461688" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Distinguishing features of idiopathic flushing and carcinoid syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1485049" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Autonomic neurodermatology (Part II): Disorders of sweating and flushing.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29423305" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Autonomic dysreflexia caused by cervical stenosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10792802" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Auriculotemporal (Frey) syndrome in late childhood: an unusual variant presenting as gustatory flushing mimicking food allergy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17569597" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Unnoticed dysautonomic syndrome of the face: Harlequin syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14996379" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : The spectrum of cutaneous reactions associated with calcium antagonists: a review of the literature and the possible etiopathogenic mechanisms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19576324" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Flushing profile of extended-release niacin/laropiprant versus gradually titrated niacin extended-release in patients with dyslipidemia with and without ischemic cardiovascular disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12638568" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : The incidence of flushing on induction of anaesthesia in patients who blush easily.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3745527" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Does monosodium glutamate cause flushing (or merely "glutamania")?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10736382" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Review of alleged reaction to monosodium glutamate and outcome of a multicenter double-blind placebo-controlled study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7771635" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Alcohol and the mystique of flushing.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11391066" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Functional relevance of human adh polymorphism.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15584875" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Alcoholism: genes and mechanisms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20224884" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: epidemiology, clinical findings, and prevention.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28645180" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Alcohol metabolism and oesophageal cancer: a systematic review of the evidence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8348446" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : The red face: drugs, chemicals and other causes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18413100" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Ethanol-induced flushing with topical pimecrolimus use.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5831899" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Distinctive clinical and therapeutic aspects of the syndrome associated with bronchial carcinoid tumors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10909039" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Mastocytosis and the skin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10200126" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Flushing as a symptom of anaphylaxis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29796277" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Facial flushing on upper limb exertion: a rare presentation of superior vena cava obstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3895809" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Clonidine in the treatment of menopausal flushing. A review of clinical studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16670414" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31799996" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Effect of Topical Brimonidine on Alcohol-Induced Flushing in Asian Individuals: A Randomized Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3426738" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Aspirin attenuation of alcohol-induced flushing and intoxication in Oriental and Occidental subjects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7171484" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Suppression of alcohol-induced flushing by a combination of H1 and H2 histamine antagonists.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2892499" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Combined antihistamine antagonism of the flushing reaction to alcohol.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18080701" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : [Interactions between ethanol and histamine].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6218789" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Effect of subdepressor clonidine on flushing reactions in rosacea. Change in malar thermal circulation index during provoked flushing reactions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2521641" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Effect of nadolol on flushing reactions in rosacea.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14616821" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Successful use of Botulinum toxin-A for the treatment of neck and anterior chest wall flushing.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10819557" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : A caution about surgical treatment for facial blushing.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
